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Differentiated Care Preferences of Stable Patients on
Antiretroviral Therapy in Zambia: A Discrete Choice
Experiment
Ingrid Eshun-Wilson, MD,a Mpande Mukumbwa-Mwenechanya, MD,b Hae-Young Kim, PhD,c
Arianna Zannolini, PhD,d Chanda P. Mwamba, PhD,b David Dowdy, PhD,e Estella Kalunkumya, PhD,b
Mwansa Lumpa, PhD,b Laura K. Beres, PhD,e Monika Roy, MD,a Anjali Sharma, PhD,b
Steph M. Topp, PhD,f Dave V. Glidden, PhD,a Nancy Padian, PhD,g Peter Ehrenkranz, PhD,h
Izukanji Sikazwe, MD,b Charles B. Holmes, MD,b,f,i Carolyn Bolton-Moore, MD,b,j and Elvin H. Geng, MDa
Background: Although differentiated service delivery (DSD)
models for stable patients on antiretroviral therapy (ART) offer
a range of health systems innovations, their comparative desirability
to patients remains unknown. We conducted a discrete choice
experiment to quantify service attributes most desired by patients
to inform model prioritization.
Methods: Between July and December 2016, a sample of HIV-
positive adults on ART at 12 clinics in Zambia were asked to choose
between 2 hypothetical facilities that differed across 6 DSD
attributes. We used mixed logit models to explore preferences,
heterogeneity, and trade-offs.
Results: Of 486 respondents, 59% were female and 85% resided in
urban locations. Patients strongly preferred infrequent clinic visits
[3- vs. 1-month visits: b (ie, relative utility) = 2.84; P , 0.001].
Milder preferences were observed for waiting time for ART pick-up
(1 vs. 6 hours.; b = 20.67; P , 0.001) or provider (1 vs. 3 hours.; b
= 20.41; P = 0.002); “buddy” ART collection (b = 0.84; P ,
0.001); and ART pick-up location (clinic vs. community: b = 0.35;
P = 0.028). Urban patients demonstrated a preference for collecting
ART at a clinic (b = 1.32, P , 0.001), and although most rural
patients preferred community ART pick-up (b = 20.74, P = 0.049),
40% of rural patients still preferred facility ART collection.
Conclusions: Stable patients on ART primarily want to attend
clinic infrequently, supporting a focus in Zambia on optimizing
multimonth prescribing over other DSD features—particularly in
urban areas. Substantial preference heterogeneity highlights the need
for DSD models to be flexible, and accommodate both setting
features and patient choice in their design.
Key Words: differentiated care, HIV, discrete choice, antiretroviral
therapy, preference
(J Acquir Immune Defic Syndr 2019;81:540–546)
INTRODUCTION
Differentiated service delivery (DSD) models for
clinically stable HIV patients in Africa may be optimally
effective when a particular model both fits with existing
health systems and matches preferences of patients in
a particular setting. At present, many promising DSD models
exist, but their comparative desirability to patients remains
incompletely understood. Facility-based individual models,
which include multimonth prescribing and “fast tracking”
primarily reduce clinical contact, and thus, opportunity costs
(the cost to the patient of attending health services in terms of
time and money) while requiring minimal changes to
logistics, infrastructure, or human resources. Other models,
which distribute antiretroviral therapy (ART) in the commu-
nity include community-based health care worker-managed
groups, client-managed groups, and out-facility individual
models. Community ART distribution in these models is
achieved through home, community venue, and mobile drug
distribution points, and in some instances, the creation of
patient groups (client-managed groups) that rotate individuals
to pick-up ART for all at the facility and distribute in the
community.1 These models may reduce geographical barriers
to care but require equipment (eg, mobile vans), patient
cooperation (for client-managed groups), or risk privacy in
the community. At this juncture, some settings have reported
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slow enrollment into DSD models2,3 while others have
concerning levels of drop-out.4–6 Given the large number of
models which national agencies must choose from, data on
the comparative desirability of DSD model features to
patients can help national health agencies prioritize their use.
Research on DSD to date has largely focused on
comparisons between a model and traditional, facility-based
care with frequent visits, but has less frequently compared
different DSD models with each other, in particular through
soliciting patient preferences for different models. Experi-
mental studies suggest4,7–9 that, in general, patients benefit
from peer support and other model components, which reduce
visit frequency and waiting time.10,11 But these studies do not
address what services patients most want. For example,
although early experience reported patient enthusiasm for
client-managed groups, it remains unknown how much of this
desire is driven by the social support from the groups as
compared to the reduced opportunity costs of treatment
afforded by membership in the group and reduced burden
of clinic visits. Although qualitative studies suggest that
client-managed groups work through both social support and
opportunity costs,10,11 these desires are not quantified vis
a vis another desired characteristic of health care. A
quantitative measure of patient preferences could advance
our understanding not only of what models work, but also
what about them works, and thereby allow evidence-based
design of differentiated care packages most appealing to
patients, subgroups, and health care settings.1
In this article, we present findings from a discrete
choice experiment (DCE) to assess the preferences of patients
receiving HIV care in Zambia. A choice experiment can
present several hypothetical scenarios of a health service to
patients. By varying the service attribute levels (eg, 2 clinics
with different waiting times and ART refill frequencies), such
an experiment can demonstrate patient preferences and the
amount of another attribute they would be willing to trade.
DCEs are gaining recognition in HIV research and have been
used to explore the patient preferences for HIV prevention
interventions,12 HIV testing,13–15 and ART services.16,17 We
used this approach in Zambia to determine what DSD features
stable patients on ART most prefer.
METHODS
Population and Sampling
We nested this study within a general survey which
formed part of a larger study evaluating the implementation of
differentiated care models in Zambia. The survey was
conducted across 3 provinces (Southern, Eastern, and Lusaka)
and 12 Ministry of Health (MoH) health care facilities
supported by Centre for Infectious Disease Research in
Zambia (CIDRZ). Facilities included 5 rural (approximately
1000–2000 patients per facility) and 7 urban sites (more than
3000 patients per facility) that were providing standard care
and no DSD interventions. A consecutive sampling technique
was used to recruit a total sample size at each site that was
proportional to the overall size of the clinic ranging from 7 to
207 patients (2.5% of total clinic population). Participants
were eligible if they were 18 years or older, gave consent to
participate in the survey and DCE, and if they were the only
household member recruited. For the survey, both ART and
non-ART patients were eligible. The DCE component was
then offered to a randomly selected subset of ART partic-
ipants. Randomization was determined through random
number generation on an electronic tablet at the time of the
survey (see Supplemental Digital Content 1, http://links.lww.
com/QAI/B323).
Selection of DSD Model Features for the
Choice Experiment
We conducted a literature review and consulted local
stakeholders to determine which DSD features (attributes)
would be most relevant in the Zambian setting. Long waiting
times, high-frequency clinic visits, and lack of support are
frequently cited barriers to retention in HIV care,10,18,19 and
these are some of the main health care features which DSD
models aim to address by adjusting visit frequency, location of
services, mode of deliver, and type of service. Current
differentiated service packages for stable patients include (1)
health care worker-managed groups, where groups meet within
or outside health care facilities, have reduced clinical visit and
ART pick-up frequency, and receive group adherence coun-
seling sessions, (2) client-managed groups which mostly
operate outside the facility, where ART collection occurs
within the community facilitated by the group, there are
infrequent clinical assessments at the health facility and group
counseling, (3) facility-based individual models where patient
ART refill visits are expedited and bypass clinic staff, and there
are infrequent clinical assessments and group adherence
counseling, and (4) out-of-facility individual models where
ART or clinic consultations are provided outside of the health
facility with individualized adherence support.1 Based on these
models, we selected 6 DSD features that were most relevant to
the Zambian setting and that were also formed part of the
intervention arms of the larger trial (Table 1). At the time of the
experiment, multimonth ART prescriptions were not available
as part of standard care in Zambia. The DSD feature levels
were determined according to guidance from local staff with
regard to current care practices regarding frequency of clinic
visits and waiting times, and what would be acceptable and
understandable to the local population. We then piloted the
DCE in 2 phases on 2 groups of 5–10 participants and
amended attribute levels, phrasing of questions and training
materials based on participant responses.
DCE Design
There was a total of 216 possible combinations of the
DSD attributes and levels that were selected for the experi-
ment (2 · 2 · 3 · 3 · 3 · 2), resulting in 23,220 total
combinations [(216 · 215)/2] across 2 clinic scenarios, clinic
A or clinic B. This number of combinations could not
possibly be presented to patients; we therefore used a frac-
tional factorial design to reduce the number of choice sets
presented to an individual patient.20 Based on good practice
guidelines, we considered that a maximum of 14 choice tasks
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would ensure response and statistical efficiency.21 We used
STATA version 14 to design a statistically efficient experi-
ment with a total of 14 choice sets in 2 blocks of 7 questions
each. The design was based on a model with 9 estimable
parameters and no interactions between attributes. The
generated design was optimally D-efficient within the con-
straints provided. To further evaluate the overall design, we
explored the correlation between attributes, which was low
overall (,0.30) (see Supplemental Digital Content 2, http://
links.lww.com/QAI/B323).
Sample Size Determination
Estimation methods for sample size determination for
DCEs vary and are dependent on the number of attributes,
levels, heterogeneity of preferences, desired level of pre-
cision, interactions between attributes, number of choice
tasks, and alternative scenarios presented in the experiment,22
and as a rule of thumb, this can be calculated as N . 500 c/(a
· t), where “c” represents the largest number of attribute
levels for any one attribute, “a” represents the number of
alternative scenarios, and “t” the number of choice tasks. For
our experiment, this resulted in a required sample size of 107
participants [(500 · 3)/(2 · 7)]; however—for robust
quantitative research where inferences are to be made to
a larger population and where no subgroup analyses are
planned—a minimum of 300 participants is recommen-
ded.20,23 Because this study was nested within a larger parent
trial and timing and resources devoted to recruitment into the
DCE were constrained by progress in the larger study, we
sought to recruit a minimum of 300 and up to 500 patients on
ART—if possible—to participate in the DCE.
Data Collection
Research assistants who had been trained on the use of
the device and administration of the questions collected data
on computer tablets. The tool was translated into the 3 main
local languages: Bemba, Nyanja, and Tonga, and research
assistants read out each question and response level to
participants in their local language. The DCE data were
collected before any other general survey questions were
undertaken to limit response fatigue. Participant demo-
graphic characteristics with regard to age, sex, marital
status, educational level, employment status, and clinic
setting were collected as part of the general survey. The
standard operating procedures for data collection are avail-
able in Supplemental Digital Content 3, http://links.lww.
com/QAI/B323.
Statistical Analysis
Descriptive characteristics were tabulated, and char-
acteristics of those who did and did not receive the DCE
were compared. To evaluate the strength of
patient preferences for DSD attributes, we used regression
models to calculate preference weights (marginal utility or
b-coefficient) and determined the mean relative preference
for each level compared with a baseline attribute level—for
example, the preference for collecting ART at a clinic was
compared with the preference for collecting ART in the
community. The b-coefficient in these models represents the
relative strength of patient preferences for an attribute level
compared with the reference level, with positive values
representing a positive preference and negative values
representing negative preferences, and higher b values
representing stronger preferences. To account for heteroge-
neity of preferences across the population, we used mixed
(random parameter) logit models. Mixed logit models
present the relative mean preference weights (b-coeffi-
cients), as well as SDs of effects across the sample, and
capture the heterogeneity across participants.20,24 All attrib-
utes were modeled as categorical variables, and we assumed
an independent covariate matrix. Goodness of fit was
determined by comparing models with different random
parameters using the Akaike information criterion, Bayesian
information criterion, and likelihood ratio tests {LR = 2 ·
[e(ll)alt 2 e(ll)null]}. Based on the results of the likelihood
ratio test, we selected a final model with random parameters
for all attributes. In a trade-off analysis, we subtracted the
absolute values of b-coefficients of all other significant
attributes from the strongest preference weight resulting in
a “b-difference,” to test what combination of attributes were
equivalent to—and what patients would be willing trade for
—their strongest preference. To explore preference hetero-
geneity, we evaluated the interaction between mean prefer-
ences and patient characteristics including age, sex, and
health care setting in the model. We maintained only the
interaction terms between health care setting and the
location of ART pick-up, and health care setting and
frequency of ART pick-up in the final model; these
interactions seemed to explain substantial heterogeneity (P
, 0.001). We further quantified preference heterogeneity
TABLE 1. Differentiated Service Features (Attributes) Selected
for DCE
DSD Attributes Levels:
Location of ART pick-up Clinic
Community*
Frequency of ART pick-up Every month
Every 3 mo
Time spent in picking up ART† 1 h total
3 h total
6 h total
Time spent in seeing the doctor‡ 1 h total
3 h total
5 h total
Adherence counseling Individual counseling
Small group counseling (,6 people)
Large group counseling (.15 people)
Buddy system§ Buddy system in place
No buddy system in place
*Community means a model where you do not have to visit the facility every time
you need an ARV refill. Examples could include mobile ART, or possibility of picking
up ARVs in some location in the community (church, school), or someone bringing the
ARVs from the facility to the community.
†Time spent at the clinic waiting to collect ARVs.
‡Time spent waiting for the doctor and seeing the doctor on a clinical visit, in
addition to time spent collecting ART.
§Means someone can pick up your meds for you if you are not due for a doctor visit.
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within rural and urban health care settings by deriving
preference probabilities from the parameters of the mixed
logit regression.25 STATA Version 14 and R statistical
software packages were used for all analyses.26,27
RESULTS
Patient Characteristics
Between July 12 and Dec 14, 2016, 1346 clinic
attendees from 12 health care facilities across 3 provinces
in Zambia were enrolled into the general survey; of these, 796
were on ART. A random sample of those on ART received
the DCE (N = 486). The 486 ART patients who received the
DCE were similar to the 310 who did not (Table 2). Most
DCE participants were female (N = 288, 59%), married (N =
294, 60%), with a minimum of primary school education (N =
366, 75%) and living in an urban setting (411, 85%). The
median age of participants was 39 years (IQR: 33–36) (Table
2). A total of 244 patients received the first block of 7
questions and 242 received the second block.
Stated Preferences for Differentiated
Service Delivery
Results from the mixed logit model (Fig. 1 and Table 3)
revealed that the strongest overall preference was for reducing
clinic visit frequency, from 1 monthly to 3 monthly visits
(preference weight: b = 2.84; 95% CI: 2.16 to 3.51; P ,
0.001), patients preferred 3 monthly visits almost 3 times
more than 1 monthly visits. Patients showed milder prefer-
ences for reducing time spent waiting at the clinic; they
preferred waiting for ART for 1 hour as opposed to the
longest waiting time of 6 hours (b = 20.67; 95% CI: 20.96
to 20.38; P , 0.001) but were less concerned about the
shorter waiting time of 3 hours compared with 1 hour (b =
20.20; 95% CI: 20.42 to 0.02; P = 0.070) and similarly
preferred waiting to see the doctor for 1 hour as opposed to 3
TABLE 2. Baseline Characteristics of DCE Eligible Participants
Characteristic:
Received DCE (N =
486), N (%)
No DCE (N =
310), N(%)
Male sex 198 (41%) 121 (39%)
Age (years; median and
interquartile range)
39 (33–46) 39 (33–45)
Marital status
Never married 54 (11%) 32 (10%)
Married 294 (60%) 200 (65%)
Living separately or
divorced
76 (16%) 42 (14%)
Widowed 62 (13%) 36 (12%)
Education level
None 120 (25%) 55 (18%)
Some primary school 251 (52%) 172 (55%)
Completed primary school 76 (16%) 59 (19%)
Higher education 39 (8%) 24 (8%)
Employment status
Employed steady wages 105 (22%) 63 (20%)
Self-employed 213 (44%) 151 (49%)
Unemployed* 168 (35%) 96 (31%)
Clinic setting
Urban 411 (85%) 281 (91%)
Rural 75 (15%) 29 (9%)
*Includes students, occasional employment, and volunteer.
FIGURE 1. Mixed logit model—preferences for DSD attributes.
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hours (b = 20.41; 95% CI: 20.67 to 20.15; P = 0.002) or 5
hours (b = 20.36; 95% CI: 20.65 to 20.07; P = 0.013).
They also indicated some preference for having a “buddy”
collect their ARVs for them at nonclinic visits as compared to
always collecting ARVs themselves (b = 0.84; 95% CI: 0.56
to 1.11; P, 0.001) and collecting medications at the clinic as
opposed to in the community (b = 0.35; 95% CI: 0.04 to 0.65;
P = 0.027). There was also a slight preference for individual
counseling compared with large group counseling (b =
20.35; 95% CI: 20.68 to 20.01; P = 0.041).
Trade-off
In the assessment of trade-offs between service features,
we determined that the preference for reducing visit fre-
quency from 1 to 3 months was equivalent to the combination
of all other significantly preferred service delivery features,
suggesting that patients were willing to give up: 1 hour of
doctor waiting time compared with 3 or 5 hours, buddy
collection of ART versus no buddy system, individual instead
of large group counseling, community ART pick-up instead
of clinic, and 1 hour of pharmacy waiting time compared with
6 hours, to attend clinic every 3 months instead of 1 monthly
(b difference = 0.23; 95% CI: 20.41 to 0.86; P = 0.487).
Preference Heterogeneity
To evaluate whether patient preferences varied by key
measurable characteristics, we entered covariates: age, sex,
and facility setting into the mixed logit model. Substantial
preference heterogeneity was demonstrated by setting (Fig.
2): there was greater preference among urban (compared with
rural) patients for collecting ART in the clinic rather than in
the community (urban-b = 1.32; 95% CI: 0.48 to 2.16; P ,
0.001 vs. rural-b = 20.74; 95% CI: 21.47 to 20.01; P =
0.049) and for reducing frequency of ART pick-ups from 1 to
3 months (urban-b = 2.19; 95% CI: 1.20 to 3.17; P , 0.001
vs. rural-b = 0.95; 95% CI: 0.18 to 1.72; P = 0.015). There
were no other interactions between differentiated care attrib-
utes and patient characteristics. The variation in preferences
between rural and urban participants regarding location for
ART collection and frequency of drug pick-up explained
some of the heterogeneity detected in preferences; however,
substantial preference heterogeneity remained across the
population, even after accounting for setting as evidenced
by persistent large and significant SDs in the mixed logit
model for several service features (see Supplemental Digital
Content 4, http://links.lww.com/QAI/B323). Preference het-
erogeneity also existed within setting subgroups (as deter-
mined through integral estimation), and although rural
participants preferred community ART collection overall,
TABLE 3. Mixed Logit Model—(a) Preferences and (b) Heterogeneity of Preferences for Differentiated Service Delivery Attributes
Attributes Preference Weight (b)
95% CI
SE PLower Upper
(a) Preferences for DSD
Waiting for ART—3 vs. 1 h* 20.20 20.42 0.02 0.11 0.070
Waiting for ART—6 vs. 1 h* 20.67 20.96 20.38 0.15 ,0.001
Waiting for Dr—3 vs. 1 h* 20.41 20.67 20.15 0.13 0.002
Waiting for Dr—5 vs. 1 h* 20.36 20.65 20.08 0.15 0.013
Location of ART pick-up—clinic vs. community* 0.35 0.04 0.65 0.16 0.028
Visits 3 monthly vs. 1 monthly* 2.84 2.16 3.51 0.34 ,0.001
Small group vs. individual* counseling 20.32 20.67 0.03 0.18 0.073
Large group vs. individual* counseling 20.35 20.68 20.01 0.17 0.040
Buddy system for ART pick vs. no buddy system* 0.83 0.56 1.11 0.14 ,0.001
Attributes SD
95% CI
SE PLower Upper
(b) Heterogeneity across preferences
Waiting for ART—3 vs. 1 h 0.55 — — 0.23 0.064
Waiting for ART—6 vs. 1 h 1.14 — — 0.24 ,0.001
Waiting for Dr—3 vs. 1 h 0.39 — — 0.35 0.265771
Waiting for Dr—5 vs. 1 h 0.99 — — 0.25 ,0.001
Location of ART pick-up—clinic vs. community 2.48 — — 0.32 ,0.001
Visits 3 monthly vs. 1 monthly 2.93 — — 0.37 ,0.001
Small group vs. individual counseling 0.54 — — 0.34 0.119998
Large group vs. individual counseling 0.42 — — 0.32 0.180119
Buddy system for ART pick vs. no buddy system 1.37 — — 0.22 ,0.001
Model specifications: log likelihood = 21611.9;
AIC = 3259.894; BIC = 3370.272
*Represents reference group for comparison.
AIC, Akaike information criterion; BIC, Bayesian information criterion; CI, confidence interval; SE, standard error; b, positive value represents positive preference, negative value
represents negative preference, higher b value represents stronger preference.
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approximately 40.1% still wanted to collect ART in the
facility, and similarly among urban participants, most (67.3%)
—but not all—preferred clinic to community ART collection.
DISCUSSION
This study demonstrates that, in this patient population,
the strongest overall preference is for reduced clinic visit
frequency, and that between patient subgroups and individ-
uals, there is substantial variation in preference. Although
other features such as buddy ART collection systems, and
reduced waiting time at the health facility were also desired, it
appeared—particularly among urban patients—that reducing
the number of clinic visits was the most valued differentiated
service feature. Patients also showed an overall preference for
collecting ART at the health facility instead of in the
community—but on stratification by location of residence,
we found a strong preference for getting treatment at a facility
among urban participants while rural patients showed, on
average, a mild preference for community ART collection.
The differences between rural and urban participants regard-
ing location of ART collection accounted for some of the
statistical heterogeneity in preferences; however, preference
heterogeneity was still evident within the rural and urban
subgroups—evidenced by large and significant SDs for
several of the estimated preference weights: even among
rural patients who as a group would like to receive care in the
community, some still prefer to get care at the facility. This
heterogeneity has been identified in other cohorts in South
Africa28 and highlights the fact that in settings where
community-based treatment is being considered by health
authorities, patients may still be given the default option of
being treated in the facility—an option that has minimal costs
for a health system.
To date, several DSD models have been shown to be
effective in retaining patients in care, and their features are
generally acceptable to patients in the short to medium
term.4,7–11,29 Scale-up, however, increases complexity, and
the choice of model, design, resource requirements, method
of implementation, and monitoring is highly context-spe-
cific.3,30 As a result, national health ministries will have to
decide which models to prioritize. This experiment provides
evidence of relative patient preferences for DSD model
features that are relevant to the Zambian context and can be
used in DSD model selection for both rural and
urban patients.
These findings suggest prioritizing and strengthening
systems, which support individual or health worker-managed
models,1 which are facility-based and focus on multimonth
prescribing in urban areas, because they are relatively easy to
implement by the health system and also conform broadly to
patient desires. For those in rural areas, health worker-
managed groups,1 client managed groups, or out-of-facility
individual models which in addition to distributing ART in
the community allow for reduced ART collection frequency
should also be considered. Although broad public health
approaches are needed to expand access to ART, some
element of patient choice should also be incorporated into
model design where possible.
This study had a number of limitations. First, the design
of the experiment was not orthogonal or balanced which are
common design features of such experiments, where all
attributes and all attribute pairs appear equally across the
experiment; however, lack of orthogonality does not preclude
parameter estimation, and near orthogonal designs such as
this one can still produce reliable preference estimates.20 In
our case, a rigorous approach was taken to design a statistical
FIGURE 2. Heterogeneity of preferences for ART collection, by setting.
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and response efficient experiment with the given number of
attributes and levels specified. Second, most patients in this
study were from an urban setting with only 15% from rural
health centers; it is possible that the full breadth of
preferences of rural participants were not represented in our
data. Third, this group of patients had never been exposed to
several of the differentiated service features that were
presented to them in the study—such as buddy pick-up
systems or community ART distribution—it is possible that
some patients could struggle to determine their preference for
care which they had never experienced. Finally, the findings
from this experiment may not be directly generalizable to
settings outside of Zambia; however, our evidence of marked
preference heterogeneity across a population and the use
a DCE to identify key features of differentiated services can
be translated to any setting.
Given the substantial preference for multimonth pre-
scriptions for all patient subgroups in this study and the
persistent desire for facility-based care—particularly in urban
areas—settings such as Zambia could consider prioritizing
implementation of multimonth prescriptions and facility-
based care in urban centers. If additional community-based
approaches are to be added for rural patients, preserving the
ability to “opt out” of community-based models (in favor of
facility-based care) would seem to allow systems to align best
with demand and preference heterogeneity, as measured in
this study.
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